Showing results (1-10 of 236) with videos related to
Sort By:
Pageof 24
World Journal of Clinical Oncology|December 18, 2015
Neuroendocrine tumors resistant to mammalian target of rapamycin inhibitors: A difficult conversion from biology to the clinicNicola FazioWorld Journal of Clinical Oncology|April 26, 2017
<i>Watch and wait</i> policy in advanced neuroendocrine tumors: What does it mean?Nicola FazioLung Cancer (Auckland, N.Z.)|August 6, 2020
Clinical Evaluation of Everolimus in the Treatment of Neuroendocrine Tumors of the Lung: Patient Selection and Special Considerations. A Systematic and Critical Review of the LiteratureMarta Peri, Nicola FazioCancer Treatment Reviews|September 17, 2016
Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: New insights and treatment implicationsNicola Fazio, Massimo MilioneCurrent Cancer Drug Targets|January 17, 2022
Gastroenteropancreatic Neuroendocrine Neoplasms (GEP NENs): The Role of Checkpoint InhibitorsGiulia Arrivi, Nicola FazioEndocrine|July 23, 2017
G3 GEP NENs category: are basic and clinical investigations well integrated?Massimo Milione, Nicola FazioEndocrine Reviews|October 9, 2025
Immune checkpoint inhibitors in high-grade gastroenteropancreatic neuroendocrine neoplasmsNicola Fazio, Anna La SalviaBest Practice & Research. Clinical Endocrinology & Metabolism|July 6, 2023
Precision medicine in gastroenteropancreatic neuroendocrine neoplasms: Where are we in 2023?Nicola Fazio, Anna La SalviaPancreas|May 21, 2021
Sex-Based Differences in Prognosis of Patients With Gastroenteropancreatic-Neuroendocrine Neoplasms: A Population-Based StudyOmar Abdel-Rahman, Nicola FazioJournal of Neuroendocrinology|April 19, 2021
Outcomes of small-cell versus large-cell gastroenteropancreatic neuroendocrine carcinomas: A population-based studyOmar Abdel-Rahman, Nicola FazioPageof 24